These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 32941815)

  • 1. Comparison of Outcomes After Ablation of Atrial Fibrillation in Patients With Heart Failure With Preserved Versus Reduced Ejection Fraction.
    Aldaas OM; Malladi CL; Mylavarapu PS; Lupercio F; Darden D; Han FT; Hoffmayer KS; Krummen D; Ho G; Raissi F; Feld GK; Hsu JC
    Am J Cardiol; 2020 Dec; 136():62-70. PubMed ID: 32941815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catheter ablation of atrial fibrillation in patients with heart failure and preserved ejection fraction.
    Black-Maier E; Ren X; Steinberg BA; Green CL; Barnett AS; Rosa NS; Al-Khatib SM; Atwater BD; Daubert JP; Frazier-Mills C; Grant AO; Hegland DD; Jackson KP; Jackson LR; Koontz JI; Lewis RK; Sun AY; Thomas KL; Bahnson TD; Piccini JP
    Heart Rhythm; 2018 May; 15(5):651-657. PubMed ID: 29222043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis of the Usefulness of Catheter Ablation of Atrial Fibrillation in Patients With Heart Failure With Preserved Ejection Fraction.
    Aldaas OM; Lupercio F; Darden D; Mylavarapu PS; Malladi CL; Han FT; Hoffmayer KS; Krummen D; Ho G; Raissi F; Birgersdotter-Green U; Feld GK; Hsu JC
    Am J Cardiol; 2021 Mar; 142():66-73. PubMed ID: 33290688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of Atrial Fibrillation Ablation in Heart Failure Subtypes.
    Younis A; Tabaja C; Santangeli P; Nakagawa H; Sipko J; Madden R; Bouscher P; Taigen T; Higuchi K; Hayashi K; El Hajjar AH; Chamseddine F; Callahan T; Martin DO; Nakhla S; Kanj M; Sroubek J; Lee JZ; Saliba WI; Wazni OM; Hussein AA
    Circ Arrhythm Electrophysiol; 2024 Sep; 17(9):e012926. PubMed ID: 39193716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrial Fibrillation Ablation in Heart Failure With Reduced vs Preserved Ejection Fraction: A Systematic Review and Meta-Analysis.
    Oraii A; McIntyre WF; Parkash R; Kowalik K; Razeghi G; Benz AP; Belley-Côté EP; Conen D; Connolly SJ; Tang ASL; Healey JS; Wong JA
    JAMA Cardiol; 2024 Jun; 9(6):545-555. PubMed ID: 38656292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrial Fibrillation in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction.
    Sartipy U; Dahlström U; Fu M; Lund LH
    JACC Heart Fail; 2017 Aug; 5(8):565-574. PubMed ID: 28711451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of catheter ablation of atrial fibrillation on long-term clinical outcomes in patients with heart failure.
    Ichijo S; Miyazaki S; Kusa S; Nakamura H; Hachiya H; Kajiyama T; Iesaka Y
    J Cardiol; 2018 Sep; 72(3):240-246. PubMed ID: 29609877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and effectiveness of left atrial appendage closure in atrial fibrillation patients with different types of heart failure.
    Liu L; Yan W; Xu X; Wan C; Liu F; Yao Q; Song L; Wang B; Song Z; Li H
    BMC Cardiovasc Disord; 2024 Aug; 24(1):430. PubMed ID: 39148039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thromboembolisms in atrial fibrillation and heart failure patients with a preserved ejection fraction (HFpEF) compared to those with a reduced ejection fraction (HFrEF).
    Sobue Y; Watanabe E; Lip GYH; Koshikawa M; Ichikawa T; Kawai M; Harada M; Inamasu J; Ozaki Y
    Heart Vessels; 2018 Apr; 33(4):403-412. PubMed ID: 29067492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catheter ablation of atrial fibrillation reduces heart failure rehospitalization in patients with heart failure with preserved ejection fraction.
    Fukui A; Tanino T; Yamaguchi T; Hirota K; Saito S; Okada N; Akioka H; Shinohara T; Yufu K; Takahashi N
    J Cardiovasc Electrophysiol; 2020 Mar; 31(3):682-688. PubMed ID: 31985099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrial resynchronization therapy in patients with atrial fibrillation and heart failure with and without systolic left ventricular dysfunction: a pilot study.
    Saksena S; Slee A; Saad M
    J Interv Card Electrophysiol; 2018 Oct; 53(1):9-17. PubMed ID: 29987682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of incident atrial fibrillation in heart failure with preserved or reduced ejection fraction: A community-based study.
    Zhang P; Chamberlain AM; Hodge DO; Cai C; Xiao PL; Han J; Jiang CY; Redfield MM; Roger VL; Cha YM
    J Cardiovasc Electrophysiol; 2020 Sep; 31(9):2275-2283. PubMed ID: 32584498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catheter ablation for non-paroxysmal atrial fibrillation accompanied by heart failure with preserved ejection fraction: feasibility and benefits in functions and B-type natriuretic peptide.
    Yamauchi R; Morishima I; Okumura K; Kanzaki Y; Morita Y; Takagi K; Nagai H; Watanabe N; Furui K; Yoshioka N; Miyazawa H; Shimojo K; Imaoka T; Sakamoto G; Murohara T
    Europace; 2021 Aug; 23(8):1252-1261. PubMed ID: 33693617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial fibrillation and risk of adverse outcomes in heart failure with reduced, mildly reduced, and preserved ejection fraction: A systematic review and meta-analysis.
    Kroshian G; Joseph J; Kinlay S; Peralta AO; Hoffmeister PS; Singh JP; Yuyun MF
    J Cardiovasc Electrophysiol; 2024 Apr; 35(4):715-726. PubMed ID: 38348517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy, safety, and outcomes of catheter ablation of atrial fibrillation in patients with heart failure with preserved ejection fraction.
    Machino-Ohtsuka T; Seo Y; Ishizu T; Sugano A; Atsumi A; Yamamoto M; Kawamura R; Machino T; Kuroki K; Yamasaki H; Igarashi M; Sekiguchi Y; Aonuma K
    J Am Coll Cardiol; 2013 Nov; 62(20):1857-65. PubMed ID: 23916940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart failure progression and mortality in atrial fibrillation patients with preserved or reduced left ventricular ejection fraction.
    Slee A; Saad M; Saksena S
    J Interv Card Electrophysiol; 2019 Sep; 55(3):325-331. PubMed ID: 30887281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrial fibrillation ablation strategies and outcome in patients with heart failure: insights from the German ablation registry.
    Eitel C; Ince H; Brachmann J; Kuck KH; Willems S; Gerds-Li JH; Tebbenjohanns J; Richardt G; Hochadel M; Senges J; Tilz RR
    Clin Res Cardiol; 2019 Jul; 108(7):815-823. PubMed ID: 30788620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term events following catheter-ablation for atrial fibrillation in heart failure with preserved ejection fraction.
    Ishiguchi H; Yoshiga Y; Shimizu A; Ueyama T; Fukuda M; Kato T; Fujii S; Hisaoka M; Uchida T; Omuro T; Okamura T; Kobayashi S; Yano M
    ESC Heart Fail; 2022 Oct; 9(5):3505-3518. PubMed ID: 35894764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of catheter ablation of atrial fibrillation in the very elderly (≥80 years old): Insights from the UC San Diego AF Ablation Registry.
    Aldaas OM; Darden D; Mylavarapu PS; Aldaas AM; Han FT; Hoffmayer KS; Krummen D; Ho G; Raissi F; Feld GK; Hsu JC
    Clin Cardiol; 2023 Dec; 46(12):1488-1494. PubMed ID: 37626475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of catheter ablation for atrial fibrillation in patients with heart failure with preserved ejection fraction: a systematic review and meta-analysis.
    Chen X; Zhang X; Fang X; Feng S
    Front Cardiovasc Med; 2024; 11():1423147. PubMed ID: 39119189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.